NHS
AI에 의해 생성된 이미지
UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care
AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨
UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.
A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.